PATENT CLAIM ANALYSIS

Application Number: 15762050
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "209100"]

Abstract:
Provided herein are optimized, recombinant influenza HA polypeptides that elicit immune responses. Also provided are compositions and kits comprising the optimized HA polypeptides as well as methods of making and using the optimized HA polypeptides.

Claim (Index 7):
The method of  claim 5  or  6 , wherein the administering comprises administering to the subject a first influenza HA polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, or SEQ ID NO:14, and wherein the method further comprising administering to the subject a second influenza HA polypeptide having an amino acid sequence different from the first influenza HA polypeptide.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 90.0
- Lexical Diversity: 1.40741
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14388726', '15051991', '15392710', '14377633', '14376689']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7677154600882158
- 35 USC 102 Novelty (BERT): 0.5331556062807193
- Combined Prediction Score: 0.7442594747074662
- Mean Citation Score: 368.001672
- Max Citation Score: 375.28708
- Similarity Product: 262.05822727033143

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test